Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 8.52
+0.13 (1.49%)
At close: Oct 23, 2026
Sinotherapeutics Market Cap
Sinotherapeutics has a market cap or net worth of 3.83 billion as of October 23, 2026. It is the 13,569th most valuable company in the world and the 3,476th biggest in China. Its market cap has decreased by 21.62% in one year.
Market Cap
3.83B
Enterprise Value
3.01B
Revenue
418.12M
Global Rank
Country Rank
#3,476 China
PE Ratio
112.14
ChartMarket Cap Chart
Since August 25, 2022, Sinotherapeutics's market cap has decreased from 6.17B to 3.83B, a decrease of -37.95%. That is a compound annual growth rate of -10.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.83B | -12.16% |
| Dec 31, 2025 | 4.36B | -3.58% |
| Dec 31, 2024 | 4.52B | -9.26% |
| Dec 29, 2023 | 4.98B | -34.45% |
| Dec 30, 2022 | 7.59B | 23.16% |
| Aug 25, 2022 | 6.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LanZhou Foci Pharmaceutical | 3.94B |
| Jiangsu Lianhuan Pharmaceutical | 3.91B |
| Jinling Pharmaceutical Company | 3.87B |
| ChengDa Pharmaceuticals | 3.85B |
| Nanjing Hicin Pharmaceutical | 3.85B |
| Hunan Hansen Pharmaceutical | 3.81B |
| Hainan Shuangcheng Pharmaceuticals | 3.76B |
| Newland Pharmaceutical | 3.74B |